ArticleAmerican journal of respiratory and critical care medicine2019
Driver Mutations in Normal Airway Epithelium Elucidate Spatiotemporal Resolution of Lung Cancer.
Open access · greenAbstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 34 citations in OpenAlex.
- Evidence for non-mucinous pulmonary lesions with adenocarcinoma in situ morphology exceeding the current 3 cm WHO threshold.Virchows Archiv : an international journal of pathology · 2026Article
- Multimodal spatial-omics reveal co-evolution of alveolar progenitors and proinflammatory niches in progression of lung precursor lesions.Cancer cell · 2026Article
- Epithelial and microenvironmental mosaicism under stress: a two-compartment model for lung cancer development in never-smokers.Frontiers in cell and developmental biology · 2026Review
- Therapeutic effects and molecular mechanisms of isorhamnetin against pulmonary diseases.Inflammopharmacology · 2026Review
- Field cancerization in urothelial carcinoma: molecular alterations and clinical implications.Journal of Cancer · 2026Review
- Persistent lineage plasticity driving lung cancer development and progression.Clinical and translational medicine · 2025Review
- Tumour- and Non-Tumour-Associated Factors That Modulate Response to PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer.Cancers · 2025Review
- Cigarette smoke and decreased DNA repair by Xeroderma Pigmentosum Group C use a double hit mechanism for epithelial cell lung carcinogenesis.Oncotarget · 2025Article
- Translating premalignant biology to accelerate non-small-cell lung cancer interception.Nature reviews. Cancer · 2025Review
- Premalignant Progression in the Lung: Knowledge Gaps and Novel Opportunities for Interception of Non-Small Cell Lung Cancer. An Official American Thoracic Society Research Statement.American journal of respiratory and critical care medicine · 2024Review
- Somatic Mutations in Normal Tissues: Calm before the Storm.Cancer discovery · 2024Article
- Validation of a Proteomic Signature of Lung Cancer Risk from Bronchial Specimens of Risk-Stratified Individuals.Cancers · 2023Article
- Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma.Genome medicine · 2022Article
- Game of clones: Battles in the field of carcinogenesis.Pharmacology & therapeutics · 2022Review
- Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer.Cancer research · 2022Article
- Chronic Exposure to Waterpipe Smoke Elicits Immunomodulatory and Carcinogenic Effects in the Lung.Cancer prevention research (Philadelphia, Pa.) · 2022Observational
- Low-Coverage Whole Genome Sequencing Using Laser Capture Microscopy with Combined Digital Droplet PCR: An Effective Tool to Study Copy Number and Kras Mutations in Early Lung Adenocarcinoma Development.International journal of molecular sciences · 2021Article
- Early Diagnosis and Screening for Lung Cancer.Cold Spring Harbor perspectives in medicine · 2021Review
- Large-scale analysis of acquired chromosomal alterations in non-tumor samples from patients with cancer.Nature biotechnology · 2020Article
- The Role of the ECM in Lung Cancer Dormancy and Outgrowth.Frontiers in oncology · 2020Review
Corrections and comments
- Commented on by
Authors and funding
24 authors at 5 institutions in 1 country.
Humam KadaraDepartment of Translational Molecular Pathology.
Smruthy SivakumarDepartment of Epidemiology.
Yasminka JakubekDepartment of Epidemiology.
F Anthony San LucasDepartment of Epidemiology.
Wenhua LangDepartment of Translational Molecular Pathology.
Tina McDowellDepartment of Translational Molecular Pathology.
Zachary WeberAvera Institute for Human Genetics, Sioux Falls, South Dakota.
Carmen BehrensDepartment of Thoracic/Head & Neck Medical Oncology.
Gareth E DaviesAvera Institute for Human Genetics, Sioux Falls, South Dakota.
Neda KalhorDepartment of Pathology.
Cesar MoranDepartment of Pathology.
Randa El-ZeinDepartment of Radiology, Houston Methodist Research Institute, Houston, Texas.
Reza MehranDepartment of Thoracic and Cardiovascular Surgery, and.
Stephen G SwisherDepartment of Thoracic and Cardiovascular Surgery, and.
Jing WangDepartment of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Jianjun ZhangDepartment of Thoracic/Head & Neck Medical Oncology.
Junya FujimotoDepartment of Translational Molecular Pathology.
Jerry FowlerDepartment of Epidemiology.
John V HeymachDepartment of Thoracic/Head & Neck Medical Oncology.
Steven DubinettDavid Geffen School of Medicine at University of California Los Angeles, Los Angeles, California; and.
Avrum E SpiraSection of Computational Biomedicine, School of Medicine, Boston University, Boston, Massachusetts.
Erik A EhliAvera Institute for Human Genetics, Sioux Falls, South Dakota.
Ignacio I WistubaDepartment of Translational Molecular Pathology.
Paul ScheetDepartment of Translational Molecular Pathology.
Avera Health · USThe University of Texas MD Anderson Cancer Center · USBoston University · USHouston Methodist · USUniversity of California, Los Angeles · US
Funding
Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8MUNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HEYMACH, JOHN V., MINNA, JOHN D. · 1996 to 2024
$57.4MStatistical Methods for Population Genomics and "Next-gen" Sequencing DataR01HG005859 · NHGRI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SCHEET, PAUL A · 2011 to 2015
$1.9MNCI NIH HHS P30 CA016672NCI NIH HHS P50 CA070907NHGRI NIH HHS R01 HG005859
Abstract
PubMed holds no abstract for this paper.
Indexed as
Genes, Tumor SuppressorMutationAdenocarcinomaAdultAgedAged, 80 and overCarcinoma, Non-Small-Cell LungCell Transformation, NeoplasticEpitheliumFemaleHumansLung NeoplasmsMaleMiddle AgedSequence Analysis, DNAallelic imbalancecancerization fielddeep targeted sequencingearly-stage non–small cell lung cancernormal airway
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.